Archives

by in
Entry Author Date Location
Oxford’s Fambrough Leaves for Dicerna, Clinical Data Aims to Take on Big Pharma with Antidepressants, Genzyme’s Termeer Courts Shareholders, & More Boston-Area Life Sciences News 05/14/10 Boston
Genzyme in “Tough Spot” with Icahn Proxy Challenge—CEO Termeer Courting Key Shareholders 05/13/10 Boston
Icahn Blasts Genzyme Manufacturing, Glaxo Halts “Red Wine” Drug Trial, Ariad Gets $69M from Merck, & More Boston-Area Life Sciences News 05/07/10 Boston
$2B Stock Buyback for Genzyme 05/06/10 Boston
Icahn Calls Genzyme’s Manufacturing “Broken,” Advises Against Termeer’s Re-Election to Board 05/04/10 Boston
Genzyme Activist Joins Board, Agios Clinches Deal With Celgene, Third Rock Seeks $400M New Fund, & More Boston-Area Life Sciences News 04/16/10 Boston
Genzyme Adds Whitworth to Board, WSJ Says 04/14/10 Boston
Biogen Idec Reaches Deal With Icahn, Ironwood CEO Shares IPO Strategy, Luke Maps out the Genetics Institute Diaspora, & More Boston-Area Life Sciences News 03/26/10 Boston
Icahn Gets One More Seat on Biogen Board 03/22/10 Boston
Biogen Idec Seeks Science-Savvy CEO, LifeImage Partners With EMC, GenomeQuest Aims to be Genetic Google, & More Boston-Area Life Sciences News 02/26/10 Boston
Icahn Making His Move On Genzyme 02/22/10 Boston
Chairman Bill Young: Next Biogen Idec CEO May Be a Scientist 02/22/10 Boston
Sirtris Founders Resurface with New Fund, Icahn Continues to Make Biotech Waves, Sentillion Bought by Microsoft, & More Boston-Area Life Sciences News 02/19/10 Boston
Icahn Boosts Genzyme Stake 02/16/10 Boston
Carl Icahn Nominates Scripps Researcher to Biogen Idec Board, BrainCells Pursues New Drug Combo for Depression, Illumina Adds to Oxford Nanopore Investment, & More San Diego Life Sciences News 02/04/10 San Diego
All Eyes On Ironwood IPO, Icahn Seeks Biogen Board Seats, Boston Scientific Settles with J&J, & More Boston-Area Life Sciences News 02/03/10 Boston
Carl Icahn Nominates Three More Candidates for Biogen Board Seats 01/28/10 Boston
Motricity Files for IPO 01/22/10 Seattle
6 Goals for Fixing Genzyme: Xconomy’s Q&A With Relational Investors’ Ralph Whitworth 01/21/10 San Diego
Agreement Between Genzyme and San Diego Activist Shareholder Suggests Truce 01/07/10 San Diego
Biogen Idec CEO Stepping Down, Ambrx Focuses on Empowered Antibodies, Intellikine Testing First Drug Candidate, & More San Diego Life Sciences News 01/07/10 San Diego
Mullen to Relinquish Biogen Idec Reins, Joule to Test Ethanol Tech, Dicerna to Team with Kyowa Hakko Kirin, & More Boston-Area Life Sciences News 01/06/10 Boston
Biogen Idec CEO Jim Mullen Stepping Down, After Tumultuous Year of Shareholder Activism 01/04/10 Boston
Scandal, Swine Flu, Shareholder Disputes, and More: 2009 Was Quite a Year for San Diego’s Life Sciences Industry 12/22/09 San Diego
Biogen Idec Board in Flux, Cubist Acquires Calixa, ImmunoGen Drug Passes Clinical Test, & More Boston-Area Life Sciences News 12/16/09 Boston
New Faces, New Vacancies on Biogen Idec Board May Foretell Another Proxy Battle 12/15/09 Boston
Biogen Idec Chairman Steps Down as Board Re-Shuffles in Wake of Icahn Arrival 12/10/09 Boston
Biogen Idec Accused Again of Excessive CEO Pay, Lousy Performance, By Big Shareholder 11/20/09 Boston
Eastbourne Capital Dumps Entire Stake in Amylin After Partial Victory in Proxy Battle 10/09/09 San Diego
Amylin CEO, Putting Boardroom Coup Behind Him, Turns Up Heat on New Diabetes Drug 09/29/09 San Diego
Page 2 of 6 « previous page · next page »